Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Receivables - Other: 2017-2022

Historic Receivables - Other for Cidara Therapeutics (CDTX) over the last 4 years, with Dec 2022 value amounting to $5.6 million.

  • Cidara Therapeutics' Receivables - Other rose 132.56% to $20.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was $20.0 million, marking a year-over-year increase of 132.56%. This contributed to the annual value of $5.6 million for FY2022, which is 100.00% up from last year.
  • Latest data reveals that Cidara Therapeutics reported Receivables - Other of $5.6 million as of FY2022, which was up 100.00% from $2.8 million recorded in FY2021.
  • In the past 5 years, Cidara Therapeutics' Receivables - Other ranged from a high of $11.1 million in FY2020 and a low of $2.8 million during FY2021.
  • For the 3-year period, Cidara Therapeutics' Receivables - Other averaged around $6.5 million, with its median value being $5.6 million (2022).
  • In the last 5 years, Cidara Therapeutics' Receivables - Other slumped by 74.77% in 2021 and then spiked by 100.00% in 2022.
  • Cidara Therapeutics' Receivables - Other (Yearly) stood at $11.1 million in 2020, then crashed by 74.77% to $2.8 million in 2021, then soared by 100.00% to $5.6 million in 2022.